A new study reveals that the cellular composition of colon tumors is far more complex than previously understood, containing diverse cell types that influence disease progression and treatment response. Researchers identified specific, rare cell populations within tumors that appear to drive resistance to standard therapies. This discovery suggests that future treatments may need to target multiple cell types simultaneously, moving beyond a one-size-fits-all approach. The findings could lead to more personalized and effective strategies for combating colon cancer, one of the most common cancers worldwide. Read the full article at: https://www.sciencedaily.com/releases/2026/04/260401071951.htm